Implications of Neuroendocrine Tumor and Diabetes Mellitus on Patient Outcomes and Care: a Matched case–control Study
Yael Kusne(WinnMed), Nina J. Karlin(Mayo Clinic Hospital), Heidi Kosiorek(Mayo Clinic in Florida), Curtiss B. Cook(Mayo Clinic in Arizona), Kyle Coppola(James A. Haley Veterans' Hospital), Kelley Rone(Mayo Clinic Hospital), Matthew Buras, Patricia M Verona(Mayo Clinic in Arizona)
Cited by 9
Related Papers
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
|New England Journal of Medicine|2021|553
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
|Journal of Clinical Investigation|2020|485
Safety Update
|Mayo Clinic Proceedings|2020|432
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
|Journal of Diabetes Science and Technology|2022|288